Filing Details

Accession Number:
0001062993-24-011568
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-31 16:56:58
Reporting Period:
2024-02-16
Accepted Time:
2024-05-31 16:56:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374690 Larimar Therapeutics Inc. LRMR Pharmaceutical Preparations (2834) 203857670
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769848 Edward Thomas Hamilton C/O Larimar Therapeutics, Inc.
Three Bala Plaza East, Suite 506
Bala Cynwyd PA 19004
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-16 57,208 $8.74 564,798 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2024-05-29 19,000 $0.00 19,000 $7.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,000 2034-05-29 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 159,433 Indirect Post Edison, LLC
Footnotes
  1. Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. (the "Company") at the offering price, which closed on February 16, 2024.
  2. The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.